Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 11/07/2021 By Sneha ShahNovember 9, 2021
Leveraged & Inverse Content Hub This Bearish Biotech ETF Is up 16% in the Past Month By Ben HernandezOctober 12, 2021
Leveraged & Inverse Content Hub These 3 Popular ETFs Are Geared Toward Tactical Plays By Ben HernandezApril 14, 2021
Leveraged & Inverse Content Hub Biden’s Infrastructure Can Put These 2 Leveraged Funds in Play By Ben HernandezApril 9, 2021
Leveraged & Inverse Content Hub Up Over 100% in 2020 and 15% in 2021, ‘LABU’ Isn’t Holding Back By Ben HernandezJanuary 12, 2021
Leveraged & Inverse Content Hub 3 Direxion ETFs Top List of Best Leveraged Performers By Ben HernandezDecember 22, 2020
Featured Stock ETFs Trade Mixed Despite Encouraging Vaccine Developments By Ian YoungNovember 18, 2020
Leveraged & Inverse Content Hub Short Sellers Back Off From Biotech ETFs By Ben HernandezSeptember 28, 2020
Leveraged & Inverse Content Hub COVID Trade: The Race for an Ounce of Prevention By DirexionAugust 21, 2020
Leveraged & Inverse Content Hub Biotech Has Been in a Steady Uptrend Even Through Covid-19 By Ben HernandezAugust 20, 2020
Leveraged & Inverse Content Hub Traders Can Look to Biotech ETFs to For a Potential Virus Cure By Ben HernandezMay 19, 2020
Leveraged & Inverse Content Hub Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Leveraged & Inverse Content Hub A Big Week for Betting On the CURE for Cancer By DirexionJune 8, 2019
Leveraged & Inverse Content Hub 5 Leveraged ETFs With Biggest 1-Month Fund Flows By Ben HernandezMay 22, 2019
Leveraged & Inverse Content Hub Stock ETFs Outpace Bond ETF Interest By $18B April By Ian YoungMay 6, 2019
Leveraged & Inverse Content Hub 5 Best-Performing Leveraged ETFs Year-to-Date By Ben HernandezMarch 29, 2019
Leveraged & Inverse Content Hub Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
